A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-naïve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms
Dongmei Wang, Dachun Chen, Meihong Xiu, Li Wang, Thomas R. Kosten, Xiangyang Zhang
Topics & Concepts
CelecoxibPositive and Negative Syndrome ScaleMedicineInternal medicinePlaceboClinical trialRepeatable Battery for the Assessment of Neuropsychological StatusSchizophrenia (object-oriented programming)OncologyRandomized controlled trialPsychiatryNeuropsychologyCognitionPsychosisPathologyAlternative medicineTryptophan and brain disordersNeuropeptides and Animal PhysiologyInflammatory mediators and NSAID effects